How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...

The White House Internship Program is a public service leadership program that provides a unique opportunity to gain valuable professional experience and build leadership skills. Learn more about ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...